CFTX-1554 is under clinical development by Eli Lilly and Co and currently in Phase I for Peripheral Neuropathic Pain.

Peripheral artery disease is the narrowing and blocking of the arteries in the legs. This process of furring up of the blood ...

Although systematic reviews have outlined the current treatment options for neuropathic ... but NNTs were calculated for many peripheral neuropathic pain conditions. The NNT for tricyclic ...

Capsaicin is under clinical development by Grunenthal and currently in Phase III for Chemotherapy Induced Peripheral Neuropathy.

Injured peripheral nerve fibers give rise ... the power to detect a positive treatment result. An increased knowledge of the mechanisms underlying pain and their translation into signs and ...

Lidocaine patches or a topical cream called capsaicin, which can be helpful for small, painful areas, block nerve conduction and can be used as a treatment for peripheral neuropathy. TENS machine ...

“Our report indicates that the nerve entrapment syndrome therapeutics industry will continue to grow robustly, propelled by the urgent need for effective treatments.” The report also highlights ...

Vertex has reported a phase 2 win that still dented confidence in its pain prospect suzetrigine. The trial linked the ...

“Suzetrigine has again demonstrated its potential to fill an important unmet need in the treatment of pain. Today's LSR results are consistent with previous studies of this pain signal inhibitor in ...